Mutagenesis analysis of T380R mutation in the envelope protein of yellow fever virus

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Huang, Yan Jang S ^a   Nuckols, John T ^b   Horne, Kate M ^a   Vanlandingham, Dana ^a   Lobigs, Mario ^c   Higgs, Stephen ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b Medical Countermeasure Systems   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

17D vaccine; Aedes aegypti; Yellow fever virus

Indexed keywords

ARGININE; THREONINE; VIRUS ENVELOPE PROTEIN;

AEDES AEGYPTI; AMINO ACID SEQUENCE; ARTICLE; DENGUE VIRUS 2; GENETIC ANALYSIS; IN VITRO STUDY; INFECTION RATE; NONHUMAN; POLYMERASE CHAIN REACTION; REVERSE GENETICS; SITE DIRECTED MUTAGENESIS; T380R GENE; VIRUS ATTACHMENT; VIRUS GENE; VIRUS INFECTIVITY; VIRUS MUTATION; VIRUS REPLICATION; VIRUS STRAIN; YELLOW FEVER FLAVIVIRUS;

AEDES; ANIMALS; DNA MUTATIONAL ANALYSIS; MICE; MUTAGENESIS; MUTATION, MISSENSE; REVERSE GENETICS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION; YELLOW FEVER VIRUS;

EID: 84897993011     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-11-60     Document Type: Article

References (15)

1. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM, Nat Med 1997 3 866 871 10.1038/nm0897-866 9256277
2. Demonstration of binding of dengue virus envelope protein to target cells. Chen Y, Maguire T, Marks RM, J Virol 1996 70 8765 8772 8971005
3. An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. Hung J-J, Hsieh M-T, Young M-J, Kao C-L, King C-C, Chang W, J Virol 2004 78 378 388 10.1128/JVI.78.1.378-388.2004 14671119
4. Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. Bhardwaj S, Holbrook M, Shope RE, Barrett AD, Watowich SJ, J Virol 2001 75 4002 4007 10.1128/JVI.75.8.4002-4007.2001 11264392
5. Structure of yellow fever virus envelope protein domain III. Volk DE, May FJ, Gandham SHA, Anderson A, Von Lindern JJ, Beasley DWC, Barrett ADT, Gorenstein DG, Virology 2009 394 12 18 10.1016/j.virol.2009.09.001 19818466
6. E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence. Lee E, Lobigs M, J Virol 2008 82 6024 6033 10.1128/JVI.02509-07 18400851
7. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. Lee E, Lobigs M, J Virol 2002 76 4901 4911 10.1128/JVI.76.10.4901-4911.2002 11967307
8. Common E protein determinants for attenuation of glycosaminoglycan- binding variants of Japanese encephalitis and West Nile viruses. Lee E, Hall RA, Lobigs M, J Virol 2004 78 8271 8280 10.1128/JVI.78.15.8271-8280.2004 15254199
9. Biological characterization of plaque-size variants of yellow fever virus in mosquitoes and mice. Miller BR, Adkins D, Acta Virol 1988 32 227 234 2902770
10. Characterization of an infectious clone of the wild-type yellow fever virus Asibi strain that is able to infect and disseminate in mosquitoes. McElroy KL, Tsetsarkin KA, Vanlandingham DL, Higgs S, J Gen Virol 2005 86 Pt 6 1747 1751 15914853
11. Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes. Erb SM, Butrapet S, Moss KJ, Luy BE, Childers T, Calvert AE, Silengo SJ, Roehrig JT, Huang CY-H, Blair CD, Virology 2010 406 328 335 10.1016/j.virol.2010.07.024 20708768
12. Role of the yellow fever virus structural protein genes in viral dissemination from the Aedes aegypti mosquito midgut. McElroy KL, Tsetsarkin KA, Vanlandingham DL, Higgs S, J Gen Virol 2006 87 Pt 10 2993 3001 16963758
13. Characterization of the antigen distribution and tissue tropisms of three phenotypically distinct yellow fever virus variants in orally infected Aedes aegypti mosquitoes. McElroy KL, Girard YA, McGee CE, Tsetsarkin KA, Vanlandingham DL, Higgs S, Vector Borne Zoonotic Dis Larchmt N 2008 8 675 687 10.1089/vbz.2007.0269
14. Heparan sulfate binding by natural eastern equine encephalitis viruses promotes neurovirulence. Gardner CL, Ebel GD, Ryman KD, Klimstra WB, Proc Natl Acad Sci USA 2011 108 16026 16031 10.1073/pnas.1110617108 21896745
15. Identification of the heparin binding site on adeno-associated virus serotype 3B (AAV-3B). Lerch TF, Chapman MS, Virology 2012 423 6 13 10.1016/j.virol.2011.10.007 22169623